Editorial
Immunisation of healthcare workers update ore than two centuries ago Edward Jenner, a country doctor from Gloucestershire, showed that vaccination with material from cowpox provided protection against smallpox. He transferred some of the material from Sarah Nelmes's cowpox to James Phipps, the eight-year-old son of his gardener, to protect him.
But even in those days, public scepticism and resistance to adopt vaccination was rife. Some went so far as to misrepresent the risks of vaccination. The Vaccination Acts (1840, 1841, 1853, 1861, 1867, 1871) were a series of laws enacted to encourage uptake of vaccinations among the general public.
Initially introduced to make vaccination universal and free, these laws later made vaccination compulsory with parents being fined if their children were not immunised. It was hugely unpopular then, and one can easily imagine the furore that would ensue now if compulsion were to be introduced.
Immunisation has come a long way since the time of Jenner, with the transformation of vaccine preparation from the live attenuated Calmette -Guerin BCG vaccine, through the early serum vaccine for hepatitis B (derived from human sources) to the now more sophisticated techniques used in the conjugate vaccines for Streptococcus pneumoniae and Haemophilus influenzae. However, concerns about side-effects from vaccinations continue in the general population and among some healthcare workers.
The speciality and the type of work of individual healthcare workers will determine the nature of the risk from infectious diseases. Local prevalence of infectious diseases and the population served are also factors that determine the vaccinations requirements. In the community, vaccination programmes depend on herd immunity in part for their effect.
The reduction of susceptible individuals leads to decreased transmission and a significant decrease in disease prevalence in the community. In the hospital, vaccination strategies encompass the above principles and afford personal protection for healthcare workers (childhood infectious diseases when they occur in adults are much more severe) but they also protect the vulnerable patient.
With the previous reports of hepatitis B outbreaks in renal units and the risk of hepatitis B infections through needlestick injuries, many healthcare workers were convinced of the benefits of the serum vaccine when it was introduced.
This enthusiasm has been sustained for the current hepatitis B vaccine derived from recombinant DNA. Protection is not universal, as demonstrated by those healthcare workers who fail to seroconvert after repeated courses of hepatitis B vaccine. Nevertheless, the majority understand the principles of and the protection afforded through vaccination, in their day-to-day work.
In recent years, the resurgence of mumps and measles in children, young adults and certain other groups has lead to the circulation of these diseases in the community and this now poses a new problem for healthcare workers. Cases have been admitted through A&E to paediatric and adult medical wards. There have been several outbreaks involving hospital exposure in susceptible individuals. Failure to recognise the disease in its early stages and delay in the implementations of infection control procedures may lead to transmission. Healthcare workers have been exposed and some have developed measles, which can be more severe in adult life.
The publication Immunisation against infectious diseases (the 'Green Book') has a dedicated chapter for healthcare workers and other disease-specific chapters include paragraphs addressing issues relating to healthcare workers.
It states that healthcare workers should have documented evidence of having received two doses of measles and rubella containing vaccine or having had positive antibody tests for measles and rubella. The measles, mumps and rubella (MMR) vaccine is especially important in preventing staff transmitting measles or rubella to vulnerable groups and will offer the individual protection to mumps.
Exposures to chickenpox in a healthcare system are not uncommon. In adults the infection can be severe and complications related to varicella pneumonia and encephalitis may lead to significant mortality. This is especially important for those working in high risk areas of haemato-oncology, neonatal intensive care, paediatrics, obstetrics and augmented care (intensive care). The most frequent place where exposure occurs, however, is in primary care.
A varicella vaccine has been available for a number of years and now offers valuable protection to those non-immune healthcare workers caring for vulnerable patients. A post-vaccination rash may occur in some individuals and healthcare workers should be informed of this prior to inoculation.
Vaccination with BCG has been available since the 1950s but with the rise in reported cases of tuberculosis in England and Wales, to over 8,000 in 2006, the need for inoculation against this important disease cannot be underestimated. However, vaccination efficacy is an issue and protection against tuberculosis is not guaranteed.
Both employers and the Department of Health have encouraged the uptake of the annual seasonal flu vaccine by healthcare workers. Despite this encouragement, uptake of this important vaccine is patchy. Poor explanation of the self-limiting side-effects following inoculation, lack of understanding about the protection afforded or apathy may explain the low uptake.
Over recent years, seasonal influenza activity has been low in the UK. Efforts by some trusts to actively promote the use of the influenza vaccine to protect the workforce have been variable. During a high prevalence year this may have a significant effect on the workforce and compromise service delivery. When the influenza pandemic does come and a pandemic flu vaccine does become available, key frontline healthcare workers will be among the first to be offered the new vaccine.
All staff should be up to date with their routine immunisations, such as tetanus, diphtheria, polio and MMR. Staff should also know their immunity to measles, rubella, varicella and hepatitis B at all times, so Ad to go here that during a nosocomial outbreak/incident a quick decision can be made about those at risk. This is also of particular importance to those healthcare workers with leukaemia or cancer and those whose immunity is altered through steroids or HIV. Healthcare workers have a responsibility to protect themselves from infectious diseases. This is a shared responsibility but the greater burden of this responsibility falls on the employer to ensure that protective vaccinations are made available.
Not all infectious diseases are preventable and not all of them are vaccine preventable. Immunisation is not a substitute for good practice. Those with direct patient contact, regular patient contact have a responsibility to protect the vulnerable patient.
Under the provisions of the Health and Safety Act all healthcare workers and employers have a responsibility to protect, so far as reasonably practicable, those at work and others who may be affected by their work activity, such as contractors, visitors and patients.
Employers need to assess the risks to staff and others to discharge their obligations under health and safety legislation. Should a vaccinepreventable infection occur in a healthcare worker, the incident must be reported through the provision of the Health and Safety Executive (1998),The reporting of injuries, diseases and dangerous occurrences regulations 1995, RIDDOR. The incident may also be reportable as a Serious Untoward Incident to the strategic health authority.
The provisions under the Health Act 2006 (Code of practice for the prevention and control of health care associated infections) and the annual declaration trusts have to make to the Healthcare Commission indicates that now is an ideal time for trusts to review their provision for staff vaccinations.
To increase vaccine uptake in healthcare workers trusts need to provide data on the level of risk and the extent of any side-effects so that staff can make an informed decision.
Dr Bharat C Patel Health Protection Agency consultant microbiologist HPA Collaborating Centre, London

